Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Orbital radiotherapy for thyroid-related orbitopathy.

Raed Behbehani1, Robert C Sergott, Peter J Savino

  • 1Neuroophthalmology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. r_behehani@hotmail.com

Current Opinion in Ophthalmology
|November 4, 2004
PubMed
Summary

Orbital radiotherapy is a safe treatment for moderate to severe thyroid-related orbitopathy. However, recent studies show conflicting results, necessitating further clinical trials for severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vogt-Koyanagi-Harada Disease Mimicking Idiopathic Intracranial Hypertension.

Neuro-ophthalmology (Aeolus Press)·2026
Same author

Racial and Ethnic Disparities in Severe Ischemic Manifestations and Tocilizumab Use Among Patients With Giant Cell Arteritis: A Nationwide Retrospective Cohort Study Using TriNetX.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same author

Non-Arteritic Anterior Ischaemic Optic Neuropathy and Its Masquerades: A Comprehensive Diagnostic Review.

Clinical & experimental ophthalmology·2026
Same author

Green vessel signal on multicolor imaging as an early sign of ischemic vasculitis in IRVAN Syndrome: A case report.

American journal of ophthalmology case reports·2026
Same author

JAK inhibitors in autoimmune ocular inflammatory diseases - A systematic review of case reports and series.

Journal of ophthalmic inflammation and infection·2025
Same author

Fluorescence lifetime imaging ophthalmoscopy adds the retina to cortical pathology for visual dysfunction in neurodegenerative diseases.

Frontiers in neurology·2025

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Radiation Oncology

Background:

  • Thyroid-related orbitopathy (TRO) is an autoimmune condition affecting the eye socket.
  • Orbital radiotherapy (ORT) is a common treatment for moderate to severe TRO.
  • Recent studies have questioned the established efficacy of ORT.

Purpose of the Study:

  • To review the role of ORT in managing moderate to severe TRO.
  • To address questions raised by recent conflicting research on ORT efficacy.
  • To evaluate ORT's safety and effectiveness in severe TRO cases.

Main Methods:

  • Literature review of existing studies on ORT for TRO.
  • Analysis of randomized clinical trials (RCTs) and observational data.
  • Synthesis of evidence regarding ORT's impact on TRO symptoms.

Related Experiment Videos

Main Results:

  • ORT is widely used and generally considered safe for TRO.
  • Limited high-quality RCTs have historically evaluated ORT's effectiveness.
  • Recent studies present conflicting findings on ORT's benefits in TRO.

Conclusions:

  • ORT remains a viable and safe treatment for severe, progressive TRO.
  • Further RCTs are crucial to clarify ORT's role, especially in severe TRO with congestion or optic neuropathy.
  • Consensus supports ORT for severe TRO, particularly when combined with corticosteroids.